Molecules like Novo Nordisk's CagriSema and Amgen's MariTide will need to demonstrate meaningful advantages beyond weight loss, such as superior cardiovascular outcomes, benefits in NASH (MASH), or other metabolic diseases, to command better pricing
2021 Mar About the Author Katie is a qualified Naturopath (BNatMed) and freelance writer from New Zealand
Unknown Long-Term Systemic Effects : No published human study has tracked BPC-157 injections beyond 12 weeks, leaving long-term organ impact, hormonal interactions, and contraindications entirely undocumented
i.e., insulins and analogues, biguanides, sulfonylureas, alpha-glucosidase inhibitors, thiazolidinediones, DPP-4is, GLP-1 RAs, sodium-glucose co-transporter 2 inhibitors, and repaglinide
Night-shift workers present a higher incidence of hormone-dependent cancer which has been related to light-induced melatonin suppression which consequently increases estrogen production